Mihika Shah, et al. “Risk of Arterial and Venous Thromboembolic Events With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis”. Global Journal of Medical Research, vol. 20, no. B1, Jan. 2020, pp. 71-85, https://medicalresearchjournal.org/index.php/GJMR/article/view/1952.